The average one-year price target for Minerva Neurosciences (NasdaqCM:NERV) has been revised to $4.59 / share. This is an increase of 12.50% from the prior estimate of $4.08 dated November 14, 2025.
The price target is an average of many targets provided by analysts. The latest targets range from a low of $4.04 to a high of $5.25 / share. The average price target represents an increase of 19.53% from the latest reported closing price of $3.84 / share.
What is the Fund Sentiment?
There are 31 funds or institutions reporting positions in Minerva Neurosciences. This is an increase of 2 owner(s) or 6.90% in the last quarter. Average portfolio weight of all funds dedicated to NERV is 0.00%, an increase of 18.28%. Total shares owned by institutions increased in the last three months by 1.81% to 1,980K shares.
What are Other Shareholders Doing?
Federated Hermes holds 1,351K shares representing 19.32% ownership of the company. No change in the last quarter.
KAUAX - Federated Kaufmann Fund Shares holds 650K shares representing 9.29% ownership of the company. No change in the last quarter.
FKASX - Federated Kaufmann Small Cap Fund Shares holds 534K shares representing 7.64% ownership of the company. No change in the last quarter.
VTSMX - Vanguard Total Stock Market Index Fund Investor Shares holds 176K shares representing 2.51% ownership of the company. No change in the last quarter.
Renaissance Technologies holds 116K shares representing 1.67% ownership of the company. In its prior filing, the firm reported owning 111K shares , representing an increase of 4.72%. The firm increased its portfolio allocation in NERV by 27.46% over the last quarter.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
